Master protocols: New directions in drug discovery

Area of Science:

• Clinical trial design
• Drug development
• Oncology research

Background:

• Master protocols offer a unified structure for clinical trials, integrating multiple subgroups and substudies.
• Originally developed for oncology, these trials efficiently evaluate multiple drugs and/or cancer types concurrently.
• They leverage a single infrastructure, design, and protocol for streamlined research.

Purpose of the Study:

• To elucidate the fundamental principles of master protocol trials.
• To highlight how innovative designs are transforming clinical research.
• To underscore the importance of understanding these advanced trial structures for professionals.

Main Methods:

• The abstract describes the conceptual framework and operational advantages of master protocols.
• It emphasizes the simultaneous evaluation of multiple investigational drugs and disease populations.
• The focus is on the unified infrastructure and single protocol approach.

Main Results:

• Master protocols accelerate drug development timelines.
• They increase the efficiency of clinical research by consolidating multiple studies.
• This approach allows for simultaneous assessment of various drugs and patient populations.

Conclusions:

• Understanding master protocol trials is crucial for clinical trial professionals.
• These innovative designs are reshaping the landscape of clinical research.
• The efficiency and speed offered by master protocols are key benefits.